Ketone Body Metabolism in CD8+ T Cell Responses

CD8 T 细胞反应中的酮体代谢

• 批准号: 10641018
• 负责人: Russell Jones
• 金额: $ 65.08万
• 依托单位: VAN ANDEL RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-06-08 至 2027-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10641018
• 关键词: Acetoacetates; Acetyl Coenzyme A; Adenosine Triphosphate; Animals; Bacteria; Bioenergetics; Blood; CD8-Positive T-Lymphocytes; CD8B1 gene; Caloric Restriction; Cell Lineage; Cell physiology; Cells; Cellular Metabolic Process; Circulation; Citric Acid Cycle; Communicable Diseases; Communities; Couples; Data; Diet; Diet Modification; Dietary Intervention; Drops; Effectiveness; Enzymes; Epigenetic Process; Esters; Fasting; Gene Expression; Genetic Transcription; Glucose; Goals; Histone Acetylation; Host Defense; Immune response; Immunity; Immunization; In Vitro; Infection; Interferon Type II; Intervention; Ketone Bodies; Ketones; Knock-out; Knowledge; Listeria; Listeriosis; Lymphocytic choriomeningitis virus; Malignant Neoplasms; Mediating; Memory; Metabolic; Metabolism; Mitochondria; Modeling; Mus; Outcome; Pathogenicity; Pathway interactions; Phase; Primary Infection; Process; Production; Research; Role; Stable Isotope Labeling; Supplementation; System; T cell differentiation; T cell response; T-Cell Activation; T-Lymphocyte; Techniques; Testing; Therapeutic Research; Virus; acute infection; adaptive immunity; beta-Hydroxybutyrate; cell mediated immune response; cytokine; dietary; effector T cell; fighting; histone modification; immunoregulation; in vivo; mouse model; novel; opportunistic pathogen; pathogen; pharmacologic; prevent; response; vaccination strategy

ABSTRACT It has been believed that infection-fighting T cells primarily use glucose to fuel host defense against viruses and bacteria; however, using new in vivo metabolite profiling techniques, it has recently been found that glucose is not the primary fuel for mitochondrial energy (ATP) production in CD8+ T cells responding to infection in vivo, particularly in later phases of infection. This presents the immunometabolism community with a critical need to define and understand the metabolites that sustain infection-fighting CD8+ T cells. This knowledge is crucial for developing effective immuno-metabolic interventions that strengthen host defense and/or enhance immunization strategies. Preliminary data point to ketone bodies—a metabolite class enriched in the blood in response to infection, fasting, and certain diets—as a key fuel for CD8+ T cell effector function, with data suggesting that ketone body availability influences T cell-mediated adaptive immunity by regulating effector function (i.e., cytokine production) at the epigenetic level. However, the full impact of T cell-intrinsic ketone body metabolism on CD8+ T cell responses remains uncharacterized. OVERALL OBJECTIVE: to characterize the mechanisms by which T cell-intrinsic ketone body metabolism (“ketolysis”) impacts CD8+ T cell metabolism and function during immune responses to infection, and to determine the role of systemic ketone body metabolism in CD8+ T cell function and host defense. HYPOTHESIS: T cell-intrinsic ketone body metabolism is a non-redundant pathway supporting host defense by fueling and directing CD8+ T cell bioenergetics and effector function in vivo. SPECIFIC AIMS: (1) Characterize ketone body metabolism in CD8+ T cells and its impact on CD8+ T cell-mediated immune responses, (2) Deconstruct the mechanisms by which ketone body metabolism impacts T cell effector function, (3) Dissect the impact of systemic ketone body metabolism on CD8+ T cell responses. IMPACT: Upon completion, this proposed research will have determined how activated CD8+ T cells utilize ketone bodies, dissected the impact of ketone bodies on CD8+ T cell effector function (primary infection clearance) and memory responses (long-term immunity), and defined how systemic ketone body availability is controlled and impacts CD8+ T cell-mediated host defense. By defining the role of ketone body metabolism in protective CD8+ T cell-mediated immune responses, we will have laid the groundwork for defining dietary and pharmacological interventions to optimize endogenous host defenses to boost clearance of infections as well as enhance immunization strategies.

摘要 据信，抗感染T细胞主要使用葡萄糖来为宿主防御病毒提供燃料 然而，使用新的体内代谢物分析技术，最近发现， 葡萄糖不是CD 8 + T细胞中线粒体能量（ATP）产生的主要燃料， 在体内感染，特别是在感染的后期阶段。这为免疫代谢界提供了 迫切需要定义和理解维持抗感染CD 8 + T细胞的代谢物。这 知识对于开发有效的免疫代谢干预措施以加强宿主防御至关重要 和/或加强免疫策略。初步数据指向酮体-一种富含 在血液中对感染、禁食和某些饮食的反应-作为CD 8 + T细胞效应功能的关键燃料， 有数据表明，酮体的利用率通过调节T细胞介导的适应性免疫， 效应子功能（即，细胞因子产生）。然而，T细胞内在的全面影响 酮体代谢对CD 8 + T细胞应答的影响仍未得到表征。 总体目的：描述T细胞-内源性酮体代谢的机制 在对感染的免疫应答期间，（“酮解”）影响CD 8 + T细胞代谢和功能，并且在对感染的免疫应答期间影响CD 8 + T细胞代谢和功能。 确定全身酮体代谢在CD 8 + T细胞功能和宿主防御中的作用。 假设：T细胞-内源性酮体代谢是支持宿主防御的非冗余途径 通过在体内激发和引导CD 8 + T细胞生物能量学和效应器功能。具体目标：（1） 表征CD 8 + T细胞中的酮体代谢及其对CD 8 + T细胞介导的免疫功能的影响 （2）解构酮体代谢影响T细胞效应功能的机制， (3)剖析全身酮体代谢对CD 8 + T细胞应答的影响。 影响：完成后，这项拟议的研究将确定活化的CD 8 + T细胞如何利用 酮体，分析酮体对CD 8 + T细胞效应功能的影响（原发性感染 清除）和记忆反应（长期免疫），并定义了全身酮体可用性如何 控制并影响CD 8 + T细胞介导的宿主防御。通过定义酮体代谢在 保护性CD 8 + T细胞介导的免疫反应，我们将为定义饮食和 药理干预，优化内源性宿主防御，促进感染清除 加强免疫战略。

项目成果

Prior metabolite extraction fully preserves RNAseq quality and enables integrative multi-'omics analysis of the liver metabolic response to viral infection.

• DOI: 10.1080/15476286.2023.2204586
• 发表时间: 2023-01
• 期刊: RNA BIOLOGY
• 影响因子: 4.1
• 作者: Madaj, Zachary B.;Dahabieh, Michael S. S.;Kamalumpundi, Vijayvardhan;Muhire, Brejnev;Pettinga, J.;Siwicki, Rebecca A. A.;Ellis, Abigail E. E.;Isaguirre, Christine;Escobar Galvis, Martha L. L.;DeCamp, Lisa;Jones, Russell G. G.;Givan, Scott A. A.;Adams, Marie;Sheldon, Ryan D. D.
• 通讯作者: Sheldon, Ryan D. D.